Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) – Investment analysts at B. Riley decreased their Q1 2025 earnings per share estimates for Aspen Aerogels in a report issued on Wednesday, February 19th. B. Riley analyst R. Pfingst now forecasts that the construction company will earn ($0.08) per share for the quarter, down from their previous estimate of $0.09. B. Riley currently has a “Buy” rating and a $22.00 target price on the stock. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.22 per share. B. Riley also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.02 EPS and FY2025 earnings at $0.22 EPS.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%.
Check Out Our Latest Stock Report on ASPN
Aspen Aerogels Price Performance
ASPN opened at $8.14 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The stock has a market capitalization of $667.48 million, a P/E ratio of 50.85 and a beta of 2.14. The company’s 50 day simple moving average is $11.85 and its 200-day simple moving average is $18.22. Aspen Aerogels has a one year low of $8.02 and a one year high of $33.15.
Hedge Funds Weigh In On Aspen Aerogels
Several institutional investors and hedge funds have recently modified their holdings of the business. Allspring Global Investments Holdings LLC lifted its stake in Aspen Aerogels by 415.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 238,884 shares of the construction company’s stock valued at $6,615,000 after buying an additional 192,520 shares in the last quarter. Dakota Wealth Management bought a new position in Aspen Aerogels during the 3rd quarter worth about $986,000. Rice Hall James & Associates LLC raised its stake in shares of Aspen Aerogels by 19.9% in the 3rd quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock valued at $14,817,000 after purchasing an additional 88,711 shares during the period. Pursue Wealth Partners LLC bought a new stake in shares of Aspen Aerogels in the third quarter valued at about $222,000. Finally, Bridgewater Advisors Inc. boosted its position in shares of Aspen Aerogels by 37.8% during the third quarter. Bridgewater Advisors Inc. now owns 77,357 shares of the construction company’s stock worth $2,142,000 after buying an additional 21,218 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.
About Aspen Aerogels
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Read More
- Five stocks we like better than Aspen Aerogels
- What is the Euro STOXX 50 Index?
- Palantir Stock Skids—How Much Further Can It Fall?
- What is the Dow Jones Industrial Average (DJIA)?
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
- 3 Small Caps With Big Return Potential
- 2 S&P 500 ETFs for Growth and Leverage in a Hot Market
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.